Search

STERIS PLC

Fermé

SecteurSoins de santé

232.91 -1.24

Résumé

Variation du prix de l'action

24h

Actuel

Min

231.86

Max

235.98

Chiffres clés

By Trading Economics

Revenu

-19M

201M

Ventes

-96M

1.5B

P/E

Moyenne du Secteur

29.065

57.002

BPA

2.59

Rendement du dividende

1.06

Marge bénéficiaire

13.466

Employés

17,937

EBITDA

-331M

349M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+16.81% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

1.06%

2.22%

Prochains Résultats

4 nov. 2026

Date du Prochain Dividende

25 sept. 2026

Date du Prochain Détachement de Dividende

3 sept. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1B

23B

Ouverture précédente

234.15

Clôture précédente

232.91

Sentiment de l'Actualité

By Acuity

34%

66%

117 / 340 Classement par Healthcare

STERIS PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

14 août 2026, 22:01 UTC

STERIS plc shares are lower in after-market hours amid concerns about consumer sentiment following an unexpected drop in U.S. retail sales for July.

13 août 2026, 23:46 UTC

STERIS plc shares are lower in after-market hours, continuing a trend of declines since Thursday's close. No specific news was identified to explain the move.

12 août 2026, 20:06 UTC

News

STERIS plc shares are lower as first-quarter results show a modest decline. The company announced a $600 million investment in a new manufacturing center.

11 août 2026, 20:01 UTC

Shares of STERIS plc are lower today, breaking a recent trend of higher daily closes. No specific news was identified for the decline.

10 août 2026, 19:43 UTC

News
Correlated Moves

STERIS shares are trading higher as Piper Sandler raised its price target to $275, despite mixed analyst ratings and target adjustments from UBS and KeyCorp.

7 août 2026, 20:02 UTC

News

Piper Sandler raised STERIS plc's price target to $275, supporting positive sentiment. The stock advanced after earlier session weakness, reflecting strong buying interest.

6 août 2026, 20:03 UTC

News

STERIS plc reported Q2 sales of $1.49 billion and adjusted EPS of $2.59, exceeding expectations. Shares are lower despite the results amid high trading volume.

5 août 2026, 22:02 UTC

News

STERIS plc shares lower in after-market hours as FY2027 EPS guidance widens, missing estimates, and first-quarter sales fall short of expectations.

4 août 2026, 20:07 UTC

News

STERIS shares are higher today, supported by broader market trends and a decline in crude oil prices. Earnings results are due August 5, 2026.

3 août 2026, 20:06 UTC

News

STERIS plc shares are higher ahead of its Q1 2027 earnings announcement. Analysts expect earnings of $2.49 per share and revenue of $1.4949 billion.

31 juil. 2026, 19:26 UTC

Social Media
News

Shares of STERIS plc are lower despite a dividend increase announcement. UBS initiated coverage with a buy rating and a target price of $275.

30 juil. 2026, 18:51 UTC

STERIS plc is lower today, driven by weakness in the Health Care Equipment sub-sector. The stock reached a session low earlier this morning.

29 juil. 2026, 20:08 UTC

Shares of STERIS plc are higher today, supported by overall market strength and notable gains in oil prices amid escalating geopolitical tensions.

28 juil. 2026, 20:13 UTC

STERIS plc shares are trading higher in after-market hours, continuing a trend of gains and remaining significantly above the 20-day moving average.

27 juil. 2026, 20:06 UTC

STERIS plc shares are higher today, reflecting gains since Friday's close, despite pulling back from an earlier session high. No specific news was identified.

24 juil. 2026, 18:06 UTC

STERIS plc shares are higher during Friday's session, having reached an early peak. No specific company news was identified to explain the movement.

21 juil. 2026, 19:06 UTC

STERIS plc is declining as Health Care Equipment sub-sector weakness weighs on shares during Tuesday's session amid unusual volatility and significant sector downward movement.

20 juil. 2026, 18:41 UTC

STERIS plc shares are lower today, continuing a downward trend since Friday. The stock remains near the upper end of its one-month trading range.

Comparaison

Variation de prix

STERIS PLC prévision

Objectif de Prix

By TipRanks

16.81% hausse

Prévisions sur 12 Mois

Moyen 272.5 USD  16.81%

Haut 275 USD

Bas 270 USD

Basé sur 3 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

3 ratings

2

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

117 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
help-icon Live chat